Ewa Fiorentino Rozek: APS – When “Unprovoked” Clots And Pregnancy Loss Connect
Ewa Fiorentino Rozek, Head of Clinical Affairs at AliveDx, shared on LinkedIn:
‘‘Antiphospholipid Syndrome (APS): when “unprovoked” clots and pregnancy loss connect
What it is: An autoimmune pro-thrombotic state causing venous/arterial thromboses and pregnancy morbidity.
It can be primary or overlap with SLE.
Patients often appear “too young” for DVT/PE or stroke; recurrent miscarriage may be the first clue.
Clinical clues: unprovoked DVT/PE, stroke/TIA under 50, livedo reticularis, thrombocytopenia, recurrent early losses or late complications in pregnancy.
Management changes dramatically if APS is confirmed—anticoagulation choices and obstetric planning differ.
Diagnostics (snapshot):
– Antibodies: anticardiolipin (aCL) and anti-β2GPI (IgG/IgM).
– Functional: lupus anticoagulant (LA).
– Key principle: persistence—positive results repeated after ~12 weeks to confirm.”
Stay updated with Hemostasis Today.
-
Nov 2, 2026, 18:08Jonathan Penm: Antithrombotic Stewardship Optimizes VTE Prophylaxis in ICU Patients
-
Nov 2, 2026, 14:48Heghine Khachatryan: Vitamin B12 Replacement Choosing the Right Route for Each Patient
-
Nov 2, 2026, 14:28Anastasia Conti: ASH Global Research Award Backs New Directions in AML Research
-
Nov 2, 2026, 14:22Sara Zalghout: Linking Bacterial Virulence to NETosis and Thromboinflammation
-
Nov 2, 2026, 13:58Functional Iron Deficiency: From Iron Sequestration to Therapeutic Targeting
-
Nov 2, 2026, 13:56Jan Terje Andersen: Albumin Engineering Opens New Routes for Erythropoietin Delivery
-
Nov 2, 2026, 13:44Rishiraj Sinha: Strengthening ISBT–AABB Collaboration in Transfusion Medicine
-
Nov 2, 2026, 13:28Jeremiah Morris: Why Blood Detection Reagents Work Better on Dry Bloodstains
-
Nov 2, 2026, 12:38Maria Τektonidou: Machine Learning – A New Approach to CVD Risk in SLE